RARA
RARA (retinoic acid receptor alpha, also known as RAR, NR1B1, RARalpha and RAR-alpha) is a ligand-regulated nuclear receptor that controls gene expression in response to all-trans and 9-cis retinoic acid. It acts as a transcription factor in development, differentiation and apoptosis. Browse Assay Genie's current range of RARA research reagents below, or read on for the biology behind the target.
RARA is a receptor for retinoic acid. Retinoic acid receptors bind as heterodimers to their target response elements when activated by their ligands, all-trans or 9-cis retinoic acid, and regulate gene expression across many biological processes. The RXR/RAR heterodimer recognises retinoic acid response elements (RARE), made up of tandem 5'-AGGTCA-3' half-sites arranged as DR1 to DR5. Without ligand, RXR-RAR heterodimers associate with a multiprotein corepressor complex that induces histone deacetylation, chromatin condensation and transcriptional suppression. On ligand binding, the corepressors dissociate and coactivators are recruited, leading to transcriptional activation. The transcription factor KLF2 might support activation and RARE binding.
Beyond this core switch, RARA has defined roles in several tissues. It is essential for retinoic acid-induced germ cell development during spermatogenesis, and it supports the survival of early spermatocytes at the start of meiotic prophase, possibly through Sertoli cells. Together with RARG it is required for skeletal growth, matrix homeostasis and growth plate function. In vascular endothelial cells, RARA with RXRA positively regulates microRNA-10a, which inhibits the GATA6/VCAM1 response to pulsatile shear stress. In association with the corepressors HDAC3, HDAC5 and HDAC7, it represses microRNA-10a and so promotes the inflammatory response.
The RARA gene encodes a member of the nuclear hormone receptor family, NR1 subfamily, within the HGNC group of retinoic acid receptors. The NCBI Gene summary links it to development, differentiation, apoptosis, granulopoiesis and transcription of clock genes. Translocations between this locus and several other loci have been associated with acute promyelocytic leukaemia, and alternatively spliced transcript variants have been described. The mouse ortholog is Rara.
RARA is a ligand-dependent transcription factor that binds RARE sites as an RXR/RAR heterodimer, switching between corepressor and coactivator complexes.
Translocations involving the RARA locus and several partner loci are associated with acute promyelocytic leukaemia, making it central to granulopoiesis studies.
RARA mediates retinoic acid-induced germ cell development and supports early spermatocyte survival during meiotic prophase in spermatogenesis.
RARA regulates microRNA-10a in endothelial shear stress responses and, with RARG, supports skeletal growth and growth plate function.
RARA is a nuclear receptor for retinoic acid. As an RXR/RAR heterodimer it binds retinoic acid response elements and represses transcription through corepressors, or activates it through coactivators once ligand is bound. It also contributes to spermatogenesis, skeletal growth and endothelial responses.
RARA is the HGNC symbol for retinoic acid receptor alpha. Aliases include RAR, NR1B1, RARalpha and RAR-alpha, and the previous name was retinoic acid receptor, alpha. The NCBI Gene record notes alternatively spliced transcript variants for this locus.
Translocations between the RARA locus and several other loci have been associated with acute promyelocytic leukaemia. The mouse ortholog is Rara; check the datasheet of any product for its validated reactivity.
Other retinoic acid receptors, retinoid X receptor partners, histone deacetylase corepressors and downstream signalling targets.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P10276; product specifications from Assay Genie datasheets.